1
Views
0
CrossRef citations to date
0
Altmetric
Research Article

RICHARD CHARLES NAIRN, FOUNDATION PROFESSOR OF PATHOLOGY AND IMMUNOLOGY AT MONASH UNIVERSITY

Pages 295-299 | Published online: 06 Jul 2009

  • Clark ACL, Dudley HAF, Hudson B, et al. An integrated final undergraduate examination. Br J Med Educ 1967; 1: 353-5.
  • Potworowski EF, Nairn RC. Specific antigenicity of thymocytes. Nature 1967; 213: 1135-6.
  • Potworowski EF, Nairn RC. Origin and fate of a thymocyte-specific antigen. Immunology 1967; 13: 597-602.
  • Nairn RC. Oedema and capillary anoxia. J Pathol Bacteriol 1958; 63: 213-34.
  • Nairn RC. The effect of reduced renal blood flow on the excretion of sodium chloride and the production of oedema in the rabbit. J Pathol Bacterial 1953; 66: 457-72.
  • Nairn RC, Chadwick CS, McEntegart MG. Fluorescent protein tracers in the study of experimental liver damage. J Pathol Bacterial 1958; 76: 143-53.
  • McEntegart MG, Chadwick CS, Nairn RC. Fluorescent antisera in the detection of serological varieties of Trichomonas vaginalis. Br J Vener Dis 1958; 34: 1-3.
  • Nairn RC, Fraser KB, Chadwick CS. The histological localization of renin with fluorescent antibody. Br J Exp Pathol 1959; 40: 155-63.
  • Nairn RC, Richmond HG, McEntegart MG, Fothergill JE. Immunological differences between normal and malignant cells. Br Med J 1960; 2: 1335-40.
  • Nairn RC, Fothergill JE, McEntegart MG, Porteous IB. Gastro-intestinal-specific antigen: an immunohistological and serological study. Br Med J 1962; 1: 1788-90.
  • Nairn RC, Fothergill JE, McEntegart MG, Richmond HG. Loss of gastrointestinal-specific antigen in neoplasia. Br Med J 1962; 1: 1791-3.
  • Nairn RC. Fluorescent Protein Tracing. 1st ed, Edinburgh, E & S Livingston, 1962.
  • Nairn RC, Chose T, Tannenberg AEG. Kidney-specific antigen depletion in human renal carcinomas. Br J Cancer 1996; 20: 756-9.
  • Muller HK, McGiven AR, Nairn RC. Immunofluorescent staining of rat gastric parietal cells by human antibody unrelated to pernicious anaemia. J Clin Pathol 1971; 24: 13-4.
  • Lewis MG, Ikonopisov RL, Nairn RC, et al. Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease. Br Med J 1969; 3: 547-52.
  • Nairn RC, Hind APP, Guli EPG, et al. Specific immune response in human skin carcinoma. Br Med J 1971; 4: 701-5.
  • Nairn RC, Nind APP, Guli EPG, et al. Immunological reactivity in patients with carcinoma of colon. Br Med J 1971; 4: 706-9.
  • Flannery GR, Chalmers PJ, Rolland JM, Nairn RC. Immune response to a syngeneic rat tumour: development of regional node lymphocyte anergy. Br J Cancer 1973; 28: 118-22.
  • Nind APP, Nairn RC, Rolland JM, et al. Lymphocyte anergy in patients with carcinoma. Br J Cancer 1973; 28: 108-17.
  • Nind APP, Matthews N, Pihl EAV, et al. Analysis of inhibition of lymphocyte cytotoxicity in human colon carcinoma. Br J Cancer 1975; 31: 620-9.
  • Pihl E, Hughes ESR, Nind APP, Nairn RC. Colonie carcinoma: clinicopathological correlation with immunoreactivity. Br Med J 1975; 3: 742-3.
  • Pihl E, Nairn RC, Nind AP, et al. Correlation of regional lymph node histology with in vitro antitumor immunoreactivity in colorectal carcinoma. Cancer Res 1976; 36: 3665-71.
  • Werkmeister JA, Pihl E, Nind APP, et al. Immunoreactivity by intrinsic lymphoid cells in colorectal carcinoma. Br J Cancer 1979; 40: 839-47.
  • Nind APP, Nairn RC, Pihl E, et al. Autochthonous humoral and cellular immunoreactivity to colorectal carcinoma: prognostic significance in 400 patients. Cancer Immunol Immunother 1980; 7: 257-61.
  • Pihl E, Nairn RC, Milne BJ, et al. Lymphoid hyperplasia: a major prognostic feature in 519 cases of colorectal carcinoma. Am J Pathol 1980; 100: 469-80.
  • Nairn RC. Standardization in immunofluorescence. Clin Exp Immunol 1968; 3: 465-76.
  • Nairn RC, Rolland JM. Fluorescent probes: a new way to study lymphocyte activation. Endeavour 1981; 5: 167-71.
  • Martin CL, Rolland JM, Nairn RC, Muller HK. Selection of optical filters for laser flow cytometry using fluorescent conjugates. Cytometry 1982; 2: 374-82.
  • Nairn RC. Lymphocyte activation studies by fluorescent probes. Ann NY Acad Sci 1984; 420: 208-14.
  • Rolland JM, Hocking GR, Nairn RC. Fluorescent lymphocyte probes for cancer detection. Ann NY Acad Sci 1984; 420: 215-8.
  • Nairn RC. Place of immunotherapy in treatment of cancer. Patient Manage 1977; 6: 57-64.
  • Nairn J. Come in Billy Nairn. Western Australia: North Stirling Press, 1980.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.